lassa
viru
lasv
singlestrand
ambisens
rna
viru
belong
arenaviru
genu
arenavirida
famili
radoshitzki
et
al
lasv
caus
acut
hemorrhag
ill
humanslassa
fever
diseas
lfd
character
fever
muscl
ach
sore
throat
nausea
vomit
chest
abdomin
pain
ogbu
et
al
howev
mild
manifest
lfd
asymptomat
infect
lasv
common
frame
et
al
ajayi
et
al
natur
host
lasv
multimamm
mous
mastomi
natalensi
persontoperson
transmiss
report
particularli
nosocomi
set
role
erythroleucu
natur
host
lasv
discuss
rodent
ubiquit
highli
commens
africa
keenlysid
et
al
monath
et
al
despit
wide
distribut
natalensi
lasv
endem
west
african
countri
includ
nigeria
sierra
leon
liberia
guinea
benin
mali
divoir
frame
et
al
safronetz
et
al
base
estim
number
lasv
infect
rang
case
endem
area
siddl
et
al
fatal
rate
ogbu
et
al
human
primarili
becom
infect
lasv
inhal
ingest
infect
rodent
excreta
addit
infect
occur
due
handl
prepar
infect
natalensi
grill
consid
delici
west
african
region
ter
meulen
et
al
persontoperson
transmiss
also
report
especi
nosocomi
set
monath
et
al
given
high
incid
fatal
lfd
sever
burden
region
health
care
moreov
lfd
one
promin
exot
viral
hemorrhag
fever
diseas
africa
macher
wolf
therefor
fast
sensit
tool
control
prevent
lasv
infect
well
clinic
diagnosi
lfd
crucial
tradit
diagnosi
lfd
done
realtim
polymeras
chain
reaction
rtpcr
later
flow
immunoassay
enzymelink
immunosorb
assay
elisa
howev
rtpcr
suitabl
detect
lasv
particularli
earli
stage
ill
high
sensit
eas
implement
studi
asogun
et
al
therefor
develop
rtpcr
assay
particularli
base
quantit
rtpcr
rtqpcr
techniqu
highli
crucial
improv
lfd
diagnosi
lasv
surveil
epidemiolog
control
studi
aim
develop
evalu
onestep
rtqpcr
assay
detect
lasvlasvfl
target
l
gene
assay
may
suitabl
detect
variou
lineag
lasv
lasv
strain
josiah
provid
virolog
biotechnolog
centr
vector
propag
use
vero
cell
cultur
commonli
avail
russian
cell
cultur
collect
concentr
viral
particl
evalu
inactiv
perform
virolog
biotechnolog
centr
vector
novosibirsk
russia
condit
armor
rna
particl
arp
synthes
biotechnolog
branch
central
research
institut
epidemiolog
moscow
russia
lasv
strain
josiah
arp
use
assess
limit
detect
lod
assay
whole
blood
sampl
natalensi
n
individu
n
pool
three
anim
provid
virolog
laboratori
hemorrhag
fever
research
project
gamal
abdel
nasser
univers
conakri
guinea
viral
rna
extract
whole
blood
natalensi
use
qiamp
viral
rna
kit
qiagen
germani
accord
manufactur
instruct
anoth
part
biolog
sampl
lung
spleen
tissu
natalensi
n
serum
human
n
collect
staff
centr
de
en
epidemiologi
microbiologi
et
soin
medicaux
crem
kindia
guinea
lung
spleen
tissu
sampl
homogen
hank
buffer
salt
solut
use
tissu
lyser
lt
qiagen
germani
suspens
centrifug
rpm
min
precipit
debri
supernat
use
viral
rna
extract
extract
nucleic
acid
sampl
collect
crem
includ
sampl
natalensi
serum
human
perform
use
riboprep
extract
kit
amplisen
russia
per
manufactur
instruct
viral
rna
examin
lassa
immedi
extract
staff
virolog
laboratori
hemorrhag
fever
research
project
gamal
abdel
nasser
univers
conakri
guinea
use
assess
diagnost
sensit
specif
onestep
rtpcr
assay
target
gp
primer
gcgcaccggggatcctaggc
agcatgtcacaaaaytcytcatcatg
use
lasv
detect
ehichioya
et
al
sequenc
lasv
l
gene
avail
genbank
ncbi
align
identifi
conserv
site
align
perform
use
bioedit
softwar
packag
ibi
bioscienc
usa
fragment
l
gene
nt
posit
refer
sequenc
lasv
strain
josiah
genbank
access
number
select
target
amplif
use
plotcon
http
emboss
bioinformaticsnlcgibinembossplotcon
primer
probe
design
accord
current
guidelin
regard
taqman
primer
probe
rtpcr
techniqu
tyagi
kramer
van
peltverkuil
et
al
melt
temperatur
primer
calcul
use
oligonucleotid
properti
calcul
http
biotoolsnubicnorthwesternedu
oligocalchtml
kibb
addit
oligonucleotid
properti
calcul
mfold
use
assess
thermodynam
characterist
probe
probabl
appear
secondari
structur
http
unafoldrnaalbanyedu
qmfold
downloadmfold
specif
lasvspecif
probe
coval
attach
fluoresc
report
dye
rhodamin
g
black
hole
quencher
end
respect
primer
probe
synthes
branch
associ
bioorgan
synthesi
central
research
institut
epidemiolog
moscow
russia
total
volum
rtqpcr
reaction
mix
includ
follow
rna
sampl
primer
probe
icdetect
primer
probe
icforwa
icreva
icprba
dntp
mm
amplisen
russia
rtpcrmix
fepfrt
amplisen
russia
mmlv
revers
transcriptas
amplisen
russia
rtgmix
amplisen
russia
taqf
polymeras
amplisen
russia
thermal
cycl
paramet
follow
min
min
cycl
fluoresc
observ
rotorgen
qiagen
germani
yellow
green
channel
specif
signal
ic
signal
respect
threshold
valu
fluoresc
chosen
middl
linear
increas
positivecontrol
fluoresc
express
logarithm
unit
amplif
result
consid
posit
level
fluoresc
cross
threshold
control
stage
rtqpcr
reaction
extern
posit
control
pcr
c
armor
recombin
posit
control
revers
transcript
arc
develop
commerci
avail
ic
icfl
amplisen
russia
use
monitor
rna
extract
purpos
icflspecif
primer
probe
ad
reaction
mixtur
addit
neg
control
extract
pcr
use
exclud
falseposit
result
due
possibl
inadvert
crosscontamin
cdna
region
bp
equival
l
gene
lasv
strain
josiah
includ
primer
probe
target
sequenc
gener
use
stepout
amplif
previous
describ
dedkov
et
al
final
pcr
product
purifi
use
minelut
gel
extract
kit
qiagen
germani
ligat
pgemt
plasmid
vector
promega
usa
transform
escherichia
coli
strain
maniati
et
al
recombin
plasmid
individu
clone
purifi
use
plasmid
miniprep
kit
axygen
usa
orient
absenc
mutat
clone
pcr
fragment
evalu
sanger
sequenc
use
abipr
xl
appli
biosystem
usa
dilut
plasmid
solut
known
concentr
use
c
furthermor
cdna
region
use
prepar
arc
base
previous
describ
procedur
arp
cheng
et
al
paslosk
et
al
certain
minor
modif
brief
pcr
fragment
contain
target
region
addit
flank
nucleotid
see
ligat
linear
inhous
plasmid
vector
contain
coat
protein
gene
verifi
dna
sequenc
gener
recombin
plasmid
transform
e
coli
strain
protein
express
induc
isopropyllthiodgalactopyranosid
induct
cell
collect
lyse
use
method
combin
lysozym
freezethaw
treat
dnase
fermenta
usa
rnase
fermenta
usa
deriv
purifi
use
cscl
gradient
centrifug
quantifi
dilut
rnalat
stabil
solut
life
technolog
usa
absenc
residu
dna
treat
sampl
verifi
use
develop
qpcr
assay
without
revers
transcript
step
c
arc
concentr
measur
system
biorad
use
pcr
supermix
probe
kit
biorad
onestep
ddpcr
supermix
probe
kit
biorad
specif
primer
suitabl
probe
per
manufactur
instruct
tabl
assess
effici
rna
extract
icfl
amplisen
russia
exogen
ic
ad
reagent
mixtur
icfl
specif
artifici
rna
sequenc
nt
gc
content
mixtur
surround
protect
protein
coat
lod
lasvfl
assay
determin
use
lasv
strain
josiah
provid
center
virolog
biotechnolog
vector
part
collect
addit
lod
assess
use
seri
dilut
arp
purpos
eight
lasv
sequenc
maxim
number
mismatch
target
region
l
gene
select
includ
sequenc
strain
josiah
also
use
gener
posit
control
gener
product
arp
describ
tabl
moreov
concentr
arp
measur
system
biorad
use
onestep
ddpcr
supermix
probe
kit
biorad
specif
primer
suitabl
probe
per
manufactur
instruct
lod
assess
use
seri
dilut
arp
lasv
strain
josiah
brief
arp
lasv
particl
known
concentr
dilut
use
rnasefre
elut
buffer
amplisen
russia
ad
intact
human
serum
make
final
volum
extract
use
riboprep
extract
kit
amplisen
russia
accord
manufactur
instruct
test
use
lasvfl
assay
establish
standard
curv
limit
detect
lod
lod
set
minim
dilut
detect
three
replic
cherpillod
et
al
potenti
crossreact
assess
use
hightit
solut
copiesml
viral
rna
dna
viral
speci
belong
viral
famili
part
collect
central
research
institut
epidemiolog
summari
rna
dna
use
studi
shown
tabl
assay
sensit
specif
determin
use
serum
sampl
patient
clinic
symptom
fever
found
lassa
posit
n
lassa
neg
n
use
whole
blood
tissu
sampl
natalensi
n
posit
n
neg
confid
interv
proport
calcul
accord
r
newcomb
deriv
procedur
outlin
e
wilson
newcomb
wilson
primer
probe
design
accord
current
guidelin
regard
taqman
primer
probe
rtpcr
techniqu
lasvspecif
probe
coval
attach
fluoresc
report
dye
rhodamin
g
black
hole
quencher
end
respect
eight
lasv
sequenc
maxim
number
mismatch
target
region
l
gene
select
gener
product
arp
lod
assess
use
arp
dilut
copiesml
copiesml
depend
arp
multipl
align
suppl
fig
sequenc
lasv
avail
genbank
begin
studi
allow
identif
highli
conserv
region
requir
design
lasvspecif
primer
respect
probe
tabl
basi
sequenc
data
oligonucleotid
primer
fluoresc
probe
design
synthes
lasvspecif
assay
develop
develop
assay
includ
compon
requir
rtqpcr
advantag
assay
allow
verif
step
analysi
includ
extract
revers
transcript
pcr
addit
use
ec
risk
falseposit
result
crosscontamin
minim
lod
assess
use
arp
dilut
copiesml
copiesml
depend
arp
lod
measur
use
lasv
strain
josiah
pfuml
tabl
standard
detect
linear
rang
copiesml
c
copiesml
c
lasv
arp
r
fig
potenti
crossreact
assess
use
hightit
rna
dna
viral
speci
none
differ
viral
speci
show
posit
reaction
lasv
rtqpcr
consequ
evalu
analyt
specif
addit
total
biolog
sampl
posit
n
neg
n
examin
lassa
previous
virolog
laboratori
hemorrhag
fever
research
project
gamal
abdel
nasser
univers
conakri
guinea
test
use
lasv
rtpcr
assay
sampl
test
posit
neg
tabl
discord
two
sampl
neg
lasvfl
assay
posit
vlhv
observ
ct
valu
posit
sampl
rang
cycl
thu
diagnost
sensit
specif
lasvfl
rtqpcr
assay
ci
respect
lasv
antigen
detect
elisa
use
lasvspecif
antibodi
niklasson
et
al
jahrl
et
al
howev
method
rel
low
sensit
rang
pfuml
jahrl
et
al
peculiar
limit
usag
particularli
earli
stage
lfd
low
viral
load
biolog
fluid
patient
addit
serolog
method
base
specif
antibodi
detect
case
lfd
use
initi
day
onset
diseas
consider
concentr
lasvspecif
igm
appear
day
salvato
et
al
howev
lack
antibodi
respons
report
fatal
case
lassa
fever
wulff
johnson
moreov
differ
antibodi
respons
depend
viru
strain
use
emmerich
et
al
therefor
rtqpcr
techniqu
suitabl
diagnosi
lasv
salvato
et
al
particularli
initi
day
lfd
onset
prefer
method
rapid
earli
diagnosi
lassa
fever
high
sensit
easi
implement
gunther
lenz
paradigm
number
rtpcr
assay
lasv
detect
develop
evalu
target
ssegment
encod
glycoprotein
precursor
nucleoprotein
limit
inform
avail
regard
lasv
sequenc
drosten
et
al
trappier
potenti
crossreact
assess
use
hightit
viral
rna
dna
viral
speci
belong
viral
famili
part
collect
central
research
institut
epidemiolog
lod
assess
use
seri
dilut
lasv
strain
josiah
provid
center
virolog
biotechnolog
vector
part
collect
et
al
dembi
et
al
trombley
et
al
howev
lasv
strain
detect
use
develop
rtpcr
trappier
et
al
new
inform
regard
sequenc
ssegment
lasv
viru
high
genet
variabl
design
reliabl
lasvspecif
primer
probe
problemat
appear
suffici
number
lgene
sequenc
facilit
design
assay
could
reliabl
lasv
detect
rna
polymeras
encod
lgene
share
conserv
amino
acid
motif
even
differ
viru
famili
poch
et
al
poch
et
al
past
year
sever
lasv
genom
complet
sequenc
lgene
sequenc
lasv
also
demonstr
high
genet
variabl
even
within
one
genet
lineag
therefor
genet
divers
lasv
natur
peculiar
like
limit
usag
rtqpcr
diagnosi
lasv
studi
develop
assay
suitabl
equal
measur
detect
broad
rang
lassa
strain
howev
lod
assay
consider
differ
depend
lasv
strain
tabl
two
discord
sampl
natalensi
neg
lasvfl
assay
posit
vlhv
found
assess
diagnost
sensit
support
assumpt
howev
success
use
routin
practic
detect
lasv
guinea
use
variou
type
sampl
includ
whole
blood
tissu
natalensi
well
serum
sampl
human
collect
day
onset
lfd
thu
assay
use
lfd
diagnosi
surveil
case
lasv
endem
fig
assay
lod
assay
standard
curv
assess
use
arp
standard
detect
linear
rang
copiesml
copiesml
lasv
arp
depend
arp
lod
set
minim
dilut
detect
three
replic
guinea
develop
assay
may
use
lasv
strain
circul
endem
territori
howev
suggest
need
confirm
studi
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
studi
evalu
approv
local
ethic
committe
pasteur
institut
saintpetersburg
russia
nation
dethiqu
pour
la
recherch
en
guinea
author
declar
compet
interest
author
express
deep
gratitud
dr
elisabeth
fichetcalvet
bernhardnocht
institut
tropic
medicin
hamburg
germani
advis
dr
barr
soropogui
convent
pcr
supervis
rodent
collect
faranah
review
earli
draft
articl
author
also
express
deep
gratitud
belov
cat
constant
presenc
write
articl
sampl
humam
serum
provid
centr
de
en
epidemiologi
microbiologi
et
soin
medicaux
crem
kindia
guinea
sampl
previous
test
lasv
use
onestep
rtpcr
assay
target
gp
ehichioya
et
al
